CDK9-IN-2

CDK9-IN-2 is a special cyclin-dependent kinase 9 (CDK9) inhibitor, extracted from patent WO/2012131594A1, compound CDKI(8), has an IC50 of 5 nM and 7 nM in H929 multiple myeloma(MM) cell line (72 hours) and A2058 skin cell line (72 hours), respectively.

Price Not Available 1mg CDK9-IN-2 Supplier Page
Catalog Number E7496
Molecular Formula C13H17NO4
CAS# 1263369-28-3
Inchi InChI=1S/C13H17NO4/c1-3-4-9-7-10(13(17)14-5-6-15)12(16)11(8-9)18-2/h3,7-8,15-16H,1,4-6H2,2H3,(H,14,17)
Inchi Key UMJHTFHIQDEGKB-UHFFFAOYSA-N
SMILES COC1=CC(=CC(=C1O)C(=O)NCCO)CC=C
Size 1mg
Supplier Page http://www.selleckchem.com/products/cdk9-in-2.html
Additional Information https://file.selleck.cn/downloads/struct/e7496-cdk9-in-2-chemical-structure-tube.png